Stay updated with breaking news from Lukas Scheibler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Covestor Ltd raised its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 564.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 797 shares of the company’s stock after purchasing an additional 677 shares during the period. Covestor Ltd’s holdings in Apellis […]
Jacob Asset Management of New York LLC raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 1,017.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,850 shares of the company’s stock after buying an additional 4,416 shares during the quarter. […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price objective cut by Citigroup from $70.00 to $67.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock. Other analysts have also recently issued reports about the company. Bank of America upgraded Apellis Pharmaceuticals from a neutral rating […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s stock price was up 3.1% during mid-day trading on Thursday . The company traded as high as $42.46 and last traded at $42.45. Approximately 19,657 shares traded hands during trading, a decline of 98% from the average daily volume of 1,062,128 shares. The stock had previously closed at […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) has earned a consensus rating of “Buy” from the fifteen analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has given a strong […]